189 related articles for article (PubMed ID: 34711278)
1. Factors influencing mass drug administration adherence and community drug distributor opportunity costs in Liberia: a mixed-methods approach.
Agboraw E; Sosu F; Dean L; Siakeh A; Thomson R; Kollie K; Worrall E
Parasit Vectors; 2021 Oct; 14(1):557. PubMed ID: 34711278
[TBL] [Abstract][Full Text] [Related]
2. A mixed methods approach to evaluating community drug distributor performance in the control of neglected tropical diseases.
Fleming FM; Matovu F; Hansen KS; Webster JP
Parasit Vectors; 2016 Jun; 9(1):345. PubMed ID: 27305942
[TBL] [Abstract][Full Text] [Related]
3. Implementation of mass drug administration for neglected tropical diseases in Guinea during the COVID-19 pandemic.
Sakho F; Badila CF; Dembele B; Diaby A; Camara AK; Lamah L; Reid SD; Weng A; Fuller BB; Sanchez KA; Kabore A; Zhang Y; Weaver A
PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009807. PubMed ID: 34570807
[TBL] [Abstract][Full Text] [Related]
4. Assessing the cost-effectiveness of integrated case management of Neglected Tropical Diseases in Liberia.
Godwin-Akpan TG; Diaconu K; Edmiston M; Smith JS; Sosu F; Weiland S; Kollie KK
BMC Health Serv Res; 2023 Jun; 23(1):705. PubMed ID: 37386431
[TBL] [Abstract][Full Text] [Related]
5. Community drug distributors for mass drug administration in neglected tropical disease programmes: systematic review and analysis of policy documents.
Macfarlane CL; Dean L; Thomson R; Garner P
J Glob Health; 2019 Dec; 9(2):020414. PubMed ID: 31662849
[TBL] [Abstract][Full Text] [Related]
6. The fight against lymphatic filariasis: perceptions of community drug distributors during mass drug administration in coastal Kenya.
Kusi C; Steinmann P; Merten S
Infect Dis Poverty; 2020 Mar; 9(1):22. PubMed ID: 32114985
[TBL] [Abstract][Full Text] [Related]
7. Community-directed distributors-The "foot soldiers" in the fight to control and eliminate neglected tropical diseases.
Amazigo UV; Leak SGA; Zoure HGM; Okoronkwo C; Diop Ly M; Isiyaku S; Crump A; Okeibunor JC; Boatin B
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009088. PubMed ID: 33661903
[TBL] [Abstract][Full Text] [Related]
8. Implementation challenges and opportunities for improved mass treatment uptake for lymphatic filariasis elimination: Perceptions and experiences of community drug distributors of coastal Kenya.
Njomo DW; Kimani BW; Kibe LW; Okoyo C; Omondi WP; Sultani HM
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0009012. PubMed ID: 33370300
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of findings from the literature and a qualitative research study on the impacts of gender, disability, and ethnicity in Neglected Tropical Diseases programs.
Arney JK; Headland MK; Bertone AM; Meite A; Ettiegne-Traore V; Asemanyi-Mensah K; Dede Teiko Dzathor I; Kargbo-Labour I; Jalloh U; Houck P; Stukel D
PLoS Negl Trop Dis; 2023 Dec; 17(12):e0011782. PubMed ID: 38048347
[TBL] [Abstract][Full Text] [Related]
10. Equity and efficiency in the scaled-up implementation of integrated neglected tropical disease control: the health economics protocol of the COUNTDOWN multicountry observational study in Ghana, Cameroon and Liberia.
Woode ME; Khan JAM; Thomson R; Niessen LW;
BMJ Open; 2018 Jun; 8(6):e020113. PubMed ID: 29961005
[TBL] [Abstract][Full Text] [Related]
11. Review of the factors influencing the motivation of community drug distributors towards the control and elimination of neglected tropical diseases (NTDs).
Krentel A; Gyapong M; Mallya S; Boadu NY; Amuyunzu-Nyamongo M; Stephens M; McFarland DA
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006065. PubMed ID: 29211746
[TBL] [Abstract][Full Text] [Related]
12. Is the neglected tropical disease mass drug administration campaign approach an effective strategy to deliver universal health coverage? A case study of the Liberia neglected tropical disease programme.
Tate A; Kollie K; Senyonjo L; Sturrock H; Downs P; Bush S; Bedell A; Molyneux D
Int Health; 2024 May; 16(3):283-292. PubMed ID: 37191201
[TBL] [Abstract][Full Text] [Related]
13. Perceptions of the roles, impact, challenges and needs of community drug distributors in the control and elimination of neglected tropical diseases in difficult-to-access communities in Ghana.
Forson AO; Awuah RB; Mohammed AR; Owusu-Asenso CM; Atakora SB; Akosah-Brempong G; Abdulai A; Sraku IK; Dhikrullahi SB; Attah SK; Afrane YA
BMC Infect Dis; 2023 Jul; 23(1):460. PubMed ID: 37430222
[TBL] [Abstract][Full Text] [Related]
14. A mixed-methods exploration into the resilience of community drug distributors conducting mass drug administration for preventive chemotherapy of lymphatic filariasis and onchocerciasis in Côte d'Ivoire and Uganda.
Dilliott D; Addiss D; Thickstun C; Djima AM; Comoe E; Thompson L; Neema S; Amuyunzu-Nyamongo M; Wung-Buh A; McFarland D; Gyapong M; Krentel A
PLOS Glob Public Health; 2022; 2(7):e0000700. PubMed ID: 36962463
[TBL] [Abstract][Full Text] [Related]
15. Financing care for Severe Stigmatizing Skin Diseases (SSSDs) in Liberia: challenges and opportunities.
Smith JS; Diaconu K; Witter S; Weiland S; Zaizay FZ; Theobald S; McCollum R; Kollie K; Kollie J; Berrian H; Hotopf I; Sempe L; Tate W; Dean L
Int J Equity Health; 2022 Nov; 21(1):160. PubMed ID: 36376897
[TBL] [Abstract][Full Text] [Related]
16. Coverage of preventive measures and surveillance for neglected tropical diseases in hard-to-reach communities in Ghana.
Forson AO; Awuah RB; Mohammed AR; Owusu-Asenso CM; Akosah-Brempong G; Abdulai A; Sraku IK; Dhikrullahi SB; Atakora SB; Attah SK; Afrane YA
BMC Public Health; 2023 Sep; 23(1):1784. PubMed ID: 37710219
[TBL] [Abstract][Full Text] [Related]
17. Community Attitudes Toward Mass Drug Administration for Control and Elimination of Neglected Tropical Diseases After the 2014 Outbreak of Ebola Virus Disease in Lofa County, Liberia.
Bogus J; Gankpala L; Fischer K; Krentel A; Weil GJ; Fischer PU; Kollie K; Bolay FK
Am J Trop Med Hyg; 2016 Mar; 94(3):497-503. PubMed ID: 26666700
[TBL] [Abstract][Full Text] [Related]
18. Achieving equity in UHC interventions: who is left behind by neglected tropical disease programmes in Cameroon?
Christine Masong M; Ozano K; Tagne MS; Tchoffo MN; Ngang S; Thomson R; Theobald S; Tchuenté LT; Kouokam E
Glob Health Action; 2021 Jan; 14(1):1886457. PubMed ID: 33641612
[No Abstract] [Full Text] [Related]
19. Optimising the performance of frontline implementers engaged in the NTD programme in Nigeria: lessons for strengthening community health systems for universal health coverage.
Oluwole A; Dean L; Lar L; Salami K; Okoko O; Isiyaku S; Dixon R; Elhassan E; Schmidt E; Thomson R; Theobald S; Ozano K
Hum Resour Health; 2019 Nov; 17(1):79. PubMed ID: 31675965
[TBL] [Abstract][Full Text] [Related]
20. Incorporating the diagnosis and management of female genital schistosomiasis in primary healthcare in Liberia: a mixed methods pilot study.
Nganda M; Bettee AK; Kollie K; Nallo GE; Juabeh M; Wright A; Thomson R; Dean L
Int Health; 2023 Mar; 15(Suppl 1):i43-i51. PubMed ID: 36960802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
